Carticept Medical
Carticept Medical develops therapies to improve the quality of life of patients with osteoarthritis or cartilage damage
About Carticept Medical
Carticept Medical, Inc., established in 2005, operated as a privately held medical device company from its headquarters in Alpharetta, Georgia. The venture was founded by Timothy J. Patrick, who brought over three decades of leadership in the medical device sector to his role as President and CEO. His prior success includes serving as President and CEO of Proxima Therapeutics, a company focused on local radiation delivery systems for cancer treatment, which was acquired in 2005 for approximately $187 million. A number of Carticept's management team also transitioned from Proxima Therapeutics, bringing a core of experienced professionals to the new enterprise.
The company's primary focus was on developing solutions for patients suffering from osteoarthritis and cartilage damage. Its flagship product was the Navigator™ Delivery System (DS), a computer-controlled drug delivery platform. This system was engineered to automate the preparation and administration of pain-relieving medications, such as corticosteroids and anesthetics, for joint injections. The Navigator DS aimed to improve upon the standard 'blind injection' practice by integrating optional ultrasound guidance for precise needle placement, a method shown to significantly increase injection accuracy. Key features included automating dose preparation directly from drug vials, which reduced manual labor, minimized contamination risks, and eliminated needle exposure for healthcare workers. Following an injection, the system would automatically record treatment data for transfer to electronic medical records, thereby enhancing practice efficiency.
Carticept Medical's business model centered on selling the Navigator DS to orthopedic and sports medicine centers. The company secured 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the Navigator DS in September 2011, with a full commercial launch planned for the first quarter of 2012. To support its operations and commercialization efforts, the company raised a total of at least $53 million through multiple funding rounds, attracting investments from major venture capital firms like Domain Associates, New Enterprise Associates, and SonoSite, Inc. Despite these milestones, later reports indicate that the company has ceased operations.
Source: Dealroom company dataNews
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES C✓Equity / VC | Jan 2012 | $10M | $40M | NEA · Sonosite · Domain Associates | — |
| SERIES B✓Equity / VC | Mar 2010 | $20M | $80M | NEA · Sonosite · Domain Associates | — |
Growth signals
Latest recorded traffic for Carticept Medical is 180 monthly website visits. Carticept Medical's team declined 33.3% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Carticept Medical in the Alpharetta ecosystem
The Carticept Medical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A3 investors entered at this stage
Domain Associates
Sonosite
NEA
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Carticept Medical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Carticept Medical’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.










